|
Originally published In Press as doi:10.1074/jbc.M002089200 on August 17, 2000
J. Biol. Chem., Vol. 275, Issue 45, 34998-35005, November 10, 2000
Ligation of HLA-DR Molecules on B Cells Induces Enhanced
Expression of IgM Heavy Chain Genes in Association with Syk
Activation*
Hiroki
Tabata §,
Takako
Matsuoka ,
Fumio
Endo§,
Yasuharu
Nishimura , and
Sho
Matsushita ¶
From the Division of Immunogenetics, Department of
Neuroscience and Immunology, Kumamoto University Graduate School of
Medical Sciences and the § Department of Pediatrics,
Kumamoto University School of Medicine, Kumamoto 860-0811, Japan
Signals transmitted by class II major
histocompatibility complex are important regarding cell function
related to antigen presentation. We examined effects of DR-mediated
signaling on Ig production from B cells. Cross-linking HLA-DR molecules
on B cells by solid-phase anti-HLA-DR monoclonal antibodies, led to an
increased production of IgM, without proliferation or apoptosis. This
event was accompanied by an enhanced expression of both membrane- and
secretory-type IgM heavy chain mRNA. When peptide-pulsed B cells
were co-incubated with an HLA-DR-restricted T cell clone treated by the
protein synthesis inhibitor emetine, peptide-induced de
novo expression of lymphokines and cell-surface molecules on T
cells can be neglected. CD40-CD154 interaction was not involved in IgM
enhancement, in such a system. The protein-tyrosine kinase inhibitors
and the Syk inhibitor piceatannol, but not the Src inhibitor PP2 had a
marked inhibitory effect on IgM secretion. Furthermore, ligation of
HLA-DR on B cells using the F(ab')2 fragment of anti-DR monoclonal
antibody, enhanced Syk activity. Our data suggest that HLA-DR on B
cells not only present antigenic peptides to T cells, but also
up-regulate IgM production, in association with Syk activation and
without the involvement of Src kinases, hence the possible
physiological relevance of Src-independent Syk activation.
*
This work was supported in part by grants-in-aid from the
Ministry of Education, Science, Sports and Culture, Japan; a research grant for intractable diseases from the Ministry of Health and Welfare,
Japan; and grants from the Sagawa Cancer Research Foundation, the
Mochida Memorial Foundation, and Japan Allergy Foundation.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence and reprint requests should be
addressed. Tel.: 81-96-373-5311; Fax: 81-96-373-5311; E-mail:
imgshom@gpo. kumamoto-u.ac.jp.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Stein, Z. Qu, S. Chen, D. Solis, H. J. Hansen, and D. M. Goldenberg
Characterization of a humanized IgG4 anti-HLA-DR monoclonal antibody that lacks effector cell functions but retains direct antilymphoma activity and increases the potency of rituximab
Blood,
October 15, 2006;
108(8):
2736 - 2744.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Zang, S. Kalache, M. Lin, B. Schroppel, and B. Murphy
MHC Class II-Mediated Apoptosis by a Nonpolymorphic MHC Class II Peptide Proceeds by Activation of Protein Kinase C
J. Am. Soc. Nephrol.,
December 1, 2005;
16(12):
3661 - 3668.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Mone, P. Huang, H. Pelicano, C. M. Cheney, J. M. Green, J. Y. Tso, A. J. Johnson, S. Jefferson, T. S. Lin, and J. C. Byrd
Hu1D10 induces apoptosis concurrent with activation of the AKT survival pathway in human chronic lymphocytic leukemia cells
Blood,
March 1, 2004;
103(5):
1846 - 1854.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Leverkus, A. D. McLellan, M. Heldmann, A. O. Eggert, E.-B. Brocker, N. Koch, and E. Kampgen
MHC class II-mediated apoptosis in dendritic cells: a role for membrane-associated and mitochondrial signaling pathways
Int. Immunol.,
August 1, 2003;
15(8):
993 - 1006.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-G. Castaigne, W. Guo, C. Leveille, D. Charron, and R. Al-Daccak
A CD18-dependent protein kinase C {beta}-mediated alternative cell death pathway of activated monocytes
Int. Immunol.,
September 1, 2002;
14(9):
1003 - 1014.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Bertho, V. M. Blancheteau, N. Setterblad, B. Laupeze, J. M. Lord, B. Drenou, L. Amiot, D. J. Charron, R. Fauchet, and N. Mooney
MHC class II-mediated apoptosis of mature dendritic cells proceeds by activation of the protein kinase C-{delta} isoenzyme
Int. Immunol.,
August 1, 2002;
14(8):
935 - 942.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-M. Yu, T. S. Hawley, R. G. Hawley, and C.-K. Qu
Role of the docking protein Gab2 in beta 1-integrin signaling pathway-mediated hematopoietic cell adhesion and migration
Blood,
April 1, 2002;
99(7):
2351 - 2359.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Matsuoka, H. Tabata, and S. Matsushita
Monocytes Are Differentially Activated Through HLA-DR, -DQ, and -DP Molecules Via Mitogen-Activated Protein Kinases
J. Immunol.,
February 15, 2001;
166(4):
2202 - 2208.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|